Drugs

First-Time Generic Drug Approvals - January 2014

 Generic Drug NameGeneric ManufacturerBrand NameApproval Date
1LAMIVUDINE TABLETS (HBV) 100 MG       HETERO LABS LIMITED UNIT VEPIVIR-HBV1/2/2014 
2LAMIVUDINE TABLETS (HBV), 100 MG       APOTEX CORP.EPIVIR-HBV TABLETS1/2/2014 
3TELMISARTAN TABLETS USP, 20 MG, 40 MG AND 80 MG     WATSON LABORATORIES, INC.MICARDIS TABLETS1/7/2014 
4TELMISARTAN AND AMLODIPINE TABLETS, 40 MG/5 MG, 40 MG/10 MG, 80 MG/5 MG AND 80 MG/10 MG    TORRENT PHARMACEUTICALS LIMITEDTWYNSTA TABLETS1/8/2014 
5SIROLIMUS TABLETS 0.5 MG       ZYDUS PHARMACEUTICALS (USA) INC.RAPAMUNE TABLETS, 0.5 MG1/8/2014 
6MYCOPHENOLIC ACID DELAYED-RELEASE TABLETS, 180 MG AND 360 MG      MYLAN PHARMACEUTICALS, INC.MYFORTIC DELAYED-RELEASE TABLETS1/8/2014 
7TELMISARTAN AND AMLODIPINE TABLETS, 40 MG/5 MG, 40 MG/10 MG, 80 MG/5 MG AND 80 MG/10 MG    LUPIN LIMITEDTWYNSTA TABLETS1/8/2014 
8DOXERCALCIFEROL CAPSULES, 1 MCG AND 2.5 MCG      ROXANE LABORATORIES, INC.HECTOROL CAPSULES1/14/2014 
9FLUOCINONIDE CREAM USP, 0.1%       PERRIGO ISRAEL PHARMACEUTICALS, LTD.VANOS CREAM1/14/2014 
10BROMFENAC OPHTHALMIC SOLUTION, 0.09% (ONCE-A-DAY)       HI-TECH PHARMACAL CO., INC.BROMDAY OPHTHALMIC SOLUTION1/22/2014 
11REPAGLINIDE TABLETS USP, 1 MG AND 2 MG      PADDOCK LABORATORIES, LLCPRANDIN TABLETS, 1 MG AND 2 MG1/22/2014 
12REPAGLINIDE TABLETS USP, 1 MG AND 2 MG      SANDOZ INC.PRANDIN TABLETS, 1 MG AND 2 MG1/22/2014 
13REPAGLINIDE TABLETS USP, 1 MG AND 2 MG      ACTAVIS TOTOWA LLCPRANDIN TABLETS, 1 MG AND 2 MG1/22/2014 
14REPAGLINIDE TABLETS USP, 1 MG AND 2 MG      MYLAN PHARMACEUTICALS INC.PRANDINTABLETS, 1 MG AND 2 MG1/22/2014 
15REPAGLINIDE TABLETS USP, 0.5 MG, 1 MG AND 2 MG     AUROBINDO PHARMA LTD.PRANDIN TABLETS1/22/2014 
16SUNITINIB MALEATE CAPSULES, 12.5 MG (BASE), 25 MG (BASE), 37.5 MG (BASE) AND 50 MG (BASE)    MYLAN PHARMACEUTICALS, INC.SUTENT CAPSULES1/30/2014 

 

 

Page Last Updated: 04/28/2015
Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.